Oro-mandibular dystonia developing with both sertraline and fluoxetine use in a female adolescent with major depressive disorder

dc.authorid0000-0002-4284-9411en_US
dc.authorid0000-0001-5207-6240en_US
dc.authorid0000-0002-3412-9879en_US
dc.authorid0000-0002-8980-6072en_US
dc.contributor.authorSarıoğlu, Setenay
dc.contributor.authorTufan, Ali Evren
dc.contributor.authorÖztürk, Yusuf
dc.contributor.authorÖzdemir, Dilara
dc.date.accessioned2023-11-20T08:25:15Z
dc.date.available2023-11-20T08:25:15Z
dc.date.issued2022en_US
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractOro-mandibular dystonia (OMD) involves repetitive uncontrollable contractions of the lower facial muscles (Scorr et al. 2021). Its etiology is not fully elucidated although various neurological (encephalitis, etc.), psychogenic and psychopharmacological (SSRIs, antipsychotics etc.) causes were implicated (Kutuk et al. 2019, Scorr et al. 2021). The odds ratio (OR) is 1.7 for dystonia in general after using SSRIs (Revet et al. 2020). Paroxetine (OR= 1.7) and fluoxetine (OR= 1.5) have the highest risks among SSRIs while escitalopram has the lowest (OR=0.8, Revet et al. 2020). Adolescent patients developing OMD after treatment with sertraline or fluoxetine alone were reported previously (Kutuk et al. 2019, Revet et al. 2020). However, OMD in a patient with sequential trials of different SSRIs are not reported up to now.en_US
dc.identifier.citationSarioglu, S., Ali, E. T., Ozturk, Y., & Ozdemir, D. (2022). Oro-Mandibular Dystonia Developing with both Sertraline and Fluoxetine Use in a Female Adolescent with Major Depressive Disorder. Psychiatry and Behavioral Sciences, 12(4), 210.en_US
dc.identifier.doi10.5455/PBS.20221012042348
dc.identifier.endpage211en_US
dc.identifier.issn2636-834X
dc.identifier.issue4en_US
dc.identifier.startpage210en_US
dc.identifier.urihttp://dx.doi.org/10.5455/PBS.20221012042348
dc.identifier.urihttps://hdl.handle.net/20.500.12491/11858
dc.identifier.volume12en_US
dc.identifier.wosWOS:000906767600007en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.institutionauthorSarıoğlu, Setenay
dc.institutionauthorTufan, Ali Evren
dc.institutionauthorÖztürk, Yusuf
dc.institutionauthorÖzdemir, Dilara
dc.language.isoenen_US
dc.publisherYerküre Tanıtım ve Yayıncılık Hizmetleri A.Ş.en_US
dc.relation.ispartofPsychiatry and Behavioral Sciencesen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectOro-Mandibular Dystoniaen_US
dc.subjectFluoxetineen_US
dc.subjectSertralineen_US
dc.subjectMajor Depressive Disorderen_US
dc.titleOro-mandibular dystonia developing with both sertraline and fluoxetine use in a female adolescent with major depressive disorderen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
setenay-sarioglu.pdf
Boyut:
279.07 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin/Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: